168 related articles for article (PubMed ID: 19414860)
21. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS
Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422
[TBL] [Abstract][Full Text] [Related]
23. Innate immunity and non-Hodgkin's lymphoma (NHL) related genes in a nested case-control study for gastric cancer risk.
Park SK; Yang JJ; Oh S; Cho LY; Ma SH; Shin A; Ko KP; Park T; Yoo KY; Kang D
PLoS One; 2012; 7(9):e45274. PubMed ID: 23028900
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia.
Shen M; Purdue MP; Kricker A; Lan Q; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Haematologica; 2007 Sep; 92(9):1180-5. PubMed ID: 17666372
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma.
Forrest MS; Skibola CF; Lightfoot TJ; Bracci PM; Willett EV; Smith MT; Holly EA; Roman E
Br J Haematol; 2006 Jul; 134(2):180-3. PubMed ID: 16740140
[TBL] [Abstract][Full Text] [Related]
26. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
Gibson TM; Smedby KE; Skibola CF; Hein DW; Slager SL; de Sanjosé S; Vajdic CM; Zhang Y; Chiu BC; Wang SS; Hjalgrim H; Nieters A; Bracci PM; Kricker A; Zheng T; Kolar C; Cerhan JR; Darabi H; Becker N; Conde L; Holford TR; Weisenburger DD; De Roos AJ; Butterbach K; Riby J; Cozen W; Benavente Y; Palmers C; Holly EA; Sampson JN; Rothman N; Armstrong BK; Morton LM
Cancer Causes Control; 2013 Jan; 24(1):125-34. PubMed ID: 23160945
[TBL] [Abstract][Full Text] [Related]
27. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
[TBL] [Abstract][Full Text] [Related]
28. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations.
Hosgood HD; Au WY; Kim HN; Liu J; Hu W; Tse J; Song B; Wong KF; Lee JJ; Chanock SJ; Siu LP; Purdue MP; Shin MH; Yu J; Liang R; Kim HJ; Rothman N; Lan Q
Int J Hematol; 2013 Jun; 97(6):793-9. PubMed ID: 23640160
[TBL] [Abstract][Full Text] [Related]
29. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
30. Single-nucleotide polymorphisms in genes encoding for CC chemokines were not associated with the risk of non-Hodgkin lymphoma.
Chen Q; Zheng T; Lan Q; Lerro C; Zhao N; Qin Q; Hu X; Huang H; Liang J; Holford T; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1332-5. PubMed ID: 23640258
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
[TBL] [Abstract][Full Text] [Related]
32. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
Cerhan JR; Novak AJ; Fredericksen ZS; Wang AH; Liebow M; Call TG; Dogan A; Witzig TE; Ansell SM; Habermann TM; Kay NE; Slager SL
Br J Haematol; 2009 Jun; 145(5):614-23. PubMed ID: 19344414
[TBL] [Abstract][Full Text] [Related]
33. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
Ye X; Zhao K; Wu C; Hu P; Fu H
Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
[TBL] [Abstract][Full Text] [Related]
34. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
[TBL] [Abstract][Full Text] [Related]
35. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.
Shen M; Zheng T; Lan Q; Zhang Y; Zahm SH; Wang SS; Holford TR; Leaderer B; Yeager M; Welch R; Kang D; Boyle P; Zhang B; Zou K; Zhu Y; Chanock S; Rothman N
Hum Genet; 2006 Jul; 119(6):659-68. PubMed ID: 16738949
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.
Wang SS; Cozen W; Severson RK; Hartge P; Cerhan JR; Davis S; Welch R; Rothman N; Chanock SJ
Hum Genet; 2006 Sep; 120(2):297-300. PubMed ID: 16783567
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma.
Suthandiram S; Gan GG; Mohd Zain S; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
Tumour Biol; 2015 Mar; 36(3):1819-34. PubMed ID: 25384508
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in integrin genes and lymphoma risk.
Shen M; Zheng T; Lan Q; Zhang Y; Hosgood HD; Zahm SH; Holford TR; Leaderer B; Yeager M; Yuenger J; Chanock S; Rothman N
Leuk Res; 2011 Jul; 35(7):968-70. PubMed ID: 21239057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
